Name: Acetorphine
Type: Opioid analgesic
AKA: N/A
|
II. Natural Derivative
Synthetic substance, no natural derivative
|
|
IV. History
Acetorphine, developed in the 1970s, is a potent synthetic opioid used in veterinary medicine. Its high potency makes it effective for anesthesia and pain management in animals, though it is not used in human medicine due to its strength and potential for abuse.
|
V. Legal Information
Acetorphine, a potent opioid, is classified as a controlled substance due to its high potential for abuse. Its status reflects regulations aimed at managing opioid use and preventing misuse.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
VI. Physical Effects
Acetorphine is a potent opioid with strong analgesic effects. As a downer, it provides significant pain relief and sedation. Short-term effects include reduced pain and euphoria, while long-term use can lead to dependence and tolerance. Overdose risks involve severe respiratory depression and potential fatality. Safe dosing requires medical supervision. Recent research focuses on its efficacy and risks of misuse. |
VII. Psychological Effects
Acetorphine, an opioid analgesic, influences opioid receptors, causing intense euphoria and cognitive impairment. Immediate effects include mood enhancement and significant pain relief, with long-term use potentially leading to dependence and psychological issues such as depression. Effects last several hours, with risks of severe mental health disturbances with chronic use.
|
VIII. Culture
Acetorphine is a potent opioid used primarily in veterinary medicine, classifying it as a downer. Short-term use provides significant analgesia, while long-term use can lead to dependence, tolerance, and severe health risks. Overdose risks are extremely high, causing severe respiratory depression and potentially fatal outcomes. Safe dosages are controlled in veterinary settings. Recent research underscores its extreme potency and risks of misuse. Physical effects include drowsiness, constricted pupils, and severe respiratory depression.
|